VOLITIONRX LTD
Profile
Company Names
VOLITIONRX LTD
Addresses
1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV 89014
1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV 89014
1 SCOTTS RD, #24-05 SHAW CENTRE, SINGAPORE, U0 228208
1 SCOTTS ROAD, #24-05 SHAW CENTRE, SINGAPORE, U0 228208
150 ORCHARD ROAD, ORCHARD PLAZA 08-02, U0 238841
150 ORCHARD ROAD, ORCHARD PLAZA 08-02, SINGAPORE, U0 238841
Phone Numbers
(512) 774-8930
1 (646) 650-1351
202-618-1750
212-618-1750
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$58,007,812.00
Number of Funding Rounds:
14
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
14
2025-05-20
$22,650,000.00
$22,650,000.00
$0.00
Debt
13
2024-03-12
$100,000.00
$100,000.00
$0.00
Equity
12
2018-08-10
$24,000,000.00
$24,000,000.00
$0.00
Equity
11
2014-11-17
$721,849.00
$721,849.00
$0.00
Equity
10
2014-10-09
$229,393.00
$229,393.00
$0.00
Equity
9
2014-09-26
$750,000.00
$750,000.00
$0.00
Equity
8
2014-09-24
$1,189,749.00
$1,189,749.00
$0.00
Equity
7
2014-02-26
$3,000,000.00
$3,000,000.00
$0.00
Equity
6
2013-11-25
$934,923.00
$1,000,000.00
$65,077.00
Equity
5
2013-06-10
$595,000.00
$1,500,000.00
$905,000.00
Equity
4
2013-05-01
$416,000.00
$500,000.00
$84,000.00
Equity
3
2013-03-25
$489,583.00
$500,000.00
$10,417.00
Equity
2
2012-04-24
$1,204,152.00
$3,000,000.00
$1,795,848.00
Equity
1
2011-10-06
$1,727,163.00
$1,727,163.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
KIM
NGUYEN
DIRECTOR
SMARTCOOL SYSTEMS INC.
| DEEPRADIOLOGY CORP
| BVI CORE Q12021-2 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q12021-1 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q12021-3 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q12021-5 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q12021-6 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q12021-4 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q22021-1 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q22021-2 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q22021-3 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q22021-4 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q22021-7 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q22021-8 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q22021-6 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| BVI CORE Q32021-1 SERIES, A SERIES OF BLU VENTURE INVESTORS CORE, LLC
| VOLITIONRX LTD
CAMERON
REYNOLDS
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Debt
2025-05-20
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
2025-05-20
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2024-03-12
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2018-08-10
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2014-11-17
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2014-09-26
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2014-10-09
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2014-09-24
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2014-02-26
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
$1 - $1,000,000
Equity
2013-11-25
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
$1 - $1,000,000
Equity
2013-06-10
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
$1 - $1,000,000
Equity
2013-05-01
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
$1 - $1,000,000
Equity
2013-03-25
D
BIOTECHNOLOGY
MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400]
$1 - $1,000,000
Equity
2012-04-24
D
BIOTECHNOLOGY
MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400]
NO REVENUES
Equity
2011-10-06
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MZ ADVISORY PTE LTD
NONE
NONE
NONE
N/A
NONE

